Matches in Wikidata for { <http://www.wikidata.org/entity/Q96583056> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- Q96583056 description "artículu científicu espublizáu en xunu de 2020" @default.
- Q96583056 description "scientific article published on 18 June 2020" @default.
- Q96583056 description "wetenschappelijk artikel" @default.
- Q96583056 description "наукова стаття, опублікована 18 червня 2020" @default.
- Q96583056 name "Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?" @default.
- Q96583056 name "Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?" @default.
- Q96583056 type Item @default.
- Q96583056 label "Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?" @default.
- Q96583056 label "Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?" @default.
- Q96583056 prefLabel "Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?" @default.
- Q96583056 prefLabel "Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?" @default.
- Q96583056 P1433 Q96583056-C65F69A5-FB4A-4D67-A5D4-755023525875 @default.
- Q96583056 P1476 Q96583056-49673274-6E2B-48E4-8C6A-5AE78A8C380C @default.
- Q96583056 P2093 Q96583056-0ED01DF3-8D4D-4331-B172-269710403339 @default.
- Q96583056 P2093 Q96583056-30C04747-BC59-4A5B-B77A-5E11443CEE6D @default.
- Q96583056 P2093 Q96583056-468E975C-FF57-4312-8C42-0978EC24834D @default.
- Q96583056 P2093 Q96583056-5A4083DE-7046-4C45-A7A6-A73869D5CCBC @default.
- Q96583056 P2093 Q96583056-5CAF9868-C1E1-482F-98B9-BF64738294A8 @default.
- Q96583056 P2093 Q96583056-5CB442F5-9996-4C72-9801-A1E8A8C73724 @default.
- Q96583056 P2093 Q96583056-7A47589E-1956-4978-88DD-F8CB9A568715 @default.
- Q96583056 P2093 Q96583056-8DACAB05-B883-4314-9ABD-580D35ED9035 @default.
- Q96583056 P2093 Q96583056-92152D9C-F651-45D2-B330-78B7B88BFA53 @default.
- Q96583056 P2093 Q96583056-A1EA67F9-3973-4B55-B307-B5B78E096057 @default.
- Q96583056 P2093 Q96583056-A635983A-C66F-4586-924E-2BAAA04B925A @default.
- Q96583056 P2093 Q96583056-AC083BFA-2EBD-4F55-89C6-2571B4504223 @default.
- Q96583056 P2093 Q96583056-B0C8CF57-4047-4AD5-BCB8-E3601DEBD4B8 @default.
- Q96583056 P2093 Q96583056-C5723837-D6C0-4B50-96C7-CD3D3D5E7275 @default.
- Q96583056 P2093 Q96583056-CDC0DD1E-A0EC-4D2D-B394-2D47093EA4A6 @default.
- Q96583056 P2093 Q96583056-CEA4759C-C66C-4B14-8ABC-A704F24CB305 @default.
- Q96583056 P2093 Q96583056-E43D1BFE-5A0E-413E-9841-B525E1787AB6 @default.
- Q96583056 P2093 Q96583056-F1FD7387-F39D-42F0-8DA6-BC14281DDA8C @default.
- Q96583056 P304 Q96583056-87249A43-83EE-459B-A160-D53E0CFED5D2 @default.
- Q96583056 P31 Q96583056-8AD6EECE-BC54-456B-97F4-EEA7EF87267B @default.
- Q96583056 P356 Q96583056-E997567E-C63B-44DA-BB13-955E3734AE9A @default.
- Q96583056 P50 Q96583056-A6AB9A3B-441C-4E5E-9D54-CCBA99B6ADF7 @default.
- Q96583056 P577 Q96583056-6F1157EA-8E29-4636-A257-87720F7EE834 @default.
- Q96583056 P698 Q96583056-A6C7174C-6114-410E-AF98-6F9E4CEC3A56 @default.
- Q96583056 P356 15287394.2020.1756592 @default.
- Q96583056 P698 32552445 @default.
- Q96583056 P1433 Q15724532 @default.
- Q96583056 P1476 "Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?" @default.
- Q96583056 P2093 "Alan Boobis" @default.
- Q96583056 P2093 "Bas J Blaauboer" @default.
- Q96583056 P2093 "Christopher J Borgert" @default.
- Q96583056 P2093 "Daniel Dietrich" @default.
- Q96583056 P2093 "Frank A Barile" @default.
- Q96583056 P2093 "Gio Batta Gori" @default.
- Q96583056 P2093 "Hans Marquardt" @default.
- Q96583056 P2093 "Helmut Greim" @default.
- Q96583056 P2093 "Herman Autrup" @default.
- Q96583056 P2093 "Herrmann Bolt" @default.
- Q96583056 P2093 "Jan Hengstler" @default.
- Q96583056 P2093 "Jose L Domingo" @default.
- Q96583056 P2093 "Kai Savolainen" @default.
- Q96583056 P2093 "Nico P Vermeulen" @default.
- Q96583056 P2093 "Pat Heslop-Harrison" @default.
- Q96583056 P2093 "Sam Kacew" @default.
- Q96583056 P2093 "Sir Colin Berry" @default.
- Q96583056 P2093 "Wolfgang Dekant" @default.
- Q96583056 P304 "1-10" @default.
- Q96583056 P31 Q13442814 @default.
- Q96583056 P356 "10.1080/15287394.2020.1756592" @default.
- Q96583056 P50 Q28028673 @default.
- Q96583056 P577 "2020-06-18T00:00:00Z" @default.
- Q96583056 P698 "32552445" @default.